Jane Street Group, LLC Corbus Pharmaceuticals Holdings, Inc. Call Options Transaction History

Jane Street Group, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Feb 15, 2022	SELL	$0.6 - $1.11 $2,220 - $4,107	-3,700 Reduced 10.63%	31,100 $19,000
Q3 2021 Nov 16, 2021	SELL	$1.01 - $1.82 $76,962 - $138,684	-76,200 Reduced 68.65%	34,800 $35,000
Q2 2021 Aug 16, 2021	SELL	$1.39 - $2.21 $38,364 - $60,996	-27,600 Reduced 19.91%	111,000 $203,000
Q1 2021 May 18, 2021	SELL	$1.27 - $3.42 $97,790 - $263,340	-77,000 Reduced 35.71%	138,600 $273,000
Q4 2020 Feb 17, 2021	SELL	$0.94 - $1.89 $578,852 - $1.16 Million	-615,800 Reduced 74.07%	215,600 $270,000
Q3 2020 Nov 17, 2020	BUY	$1.5 - $9.38 $1.01 Million - $6.3 Million	671,200 Added 418.98%	831,400 $1.5 Million
Q2 2020 Aug 17, 2020	BUY	$4.79 - $8.39 $767,358 - $1.34 Million	160,200 New	160,200 $1.34 Million

38.7K

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $2.62B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.